Welcome to our dedicated page for EPAM Systems news (Ticker: $EPAM), a resource for investors and traders seeking the latest updates and insights on EPAM Systems stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EPAM Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EPAM Systems's position in the market.
EPAM Systems, Inc. reported first-quarter revenues of $1.165 billion, down 3.8% year-over-year. GAAP income from operations was 9.5% of revenues, with non-GAAP income at 14.9%. GAAP diluted EPS was $1.97, an increase of $0.24, while non-GAAP diluted EPS was $2.46, a decrease of $0.01 year-over-year. EPAM updated full-year revenue outlook to be in the range of $4.575 billion to $4.675 billion. For the second quarter, expected revenues are between $1.135 billion to $1.145 billion.